Pharmaceuticals: Netherlands Industry Guide

Datamonitor's Pharmaceuticals: Netherlands Industry Guide is an essential resource for top-level data and analysis covering the Netherlands Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis with distinct chapters for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals

Scope of the Report

* Contains an executive summary and data on value, volume and segmentation for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals

* Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies

* Incorporates in-depth five forces competitive environment analysis and scorecards

* Includes five-year forecasts for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals

Highlights

* The Dutch pharmaceuticals market generated total revenues of $6,194.8 million in 2008, representing a compound annual growth rate (CAGR) of 3.4% for the period spanning 2005-2009.

* The Dutch OTC pharmaceuticals market generated total revenues of $1 billion in 2008, representing a compound annual growth rate (CAGR) of 2.7% for the period spanning 2004-2008.

* The Dutch biotechnology market generated total revenues of $340.3 million in 2008, representing a compound annual growth rate (CAGR) of 7.9% for the period spanning 2004-2008.

* The Dutch generics market generated total revenues of $766.7 million in 2008, representing a compound annual growth rate (CAGR) of 19.8% for the period spanning 2004-2008.

Why you should buy this report

* Spot future trends and developments

* Inform your business decisions

* Add weight to presentations and marketing materials

* Save time carrying out entry-level research


Report Highlights

[Studien Infos ausblenden]

TABLE OF CONTENTS
CHAPTER 1 BIOTECHNOLOGY IN THE NETHERLANDS 10
1.1 Market Overview 10
1.2 Market Value 12
1.3 Market Segmentation I 13
1.4 Market Segmentation II 14
1.5 Five Forces Analysis 15
1.6 Market Forecasts 21
CHAPTER 2 GENERICS IN THE NETHERLANDS 22
2.1 Market Overview 22
2.2 Market Value 24
2.3 Market Segmentation I 25
2.4 Market Segmentation II 26
2.5 Five Forces Analysis 27
2.6 Market Forecasts 34
CHAPTER 3 OTC PHARMACEUTICALS IN THE NETHERLANDS 35
3.1 Market Overview 35
3.2 Market Value 37
3.3 Market Segmentation I 38
3.4 Market Segmentation II 39
3.5 Market Share 40
3.6 Five Forces Analysis 41
3.7 Distribution 49
3.8 Market Forecasts 50
CHAPTER 4 PHARMACEUTICALS IN THE NETHERLANDS 51
4.1 Market Overview 51
4.2 Market Value 53
4.3 Market Segmentation I 54
4.4 Market Segmentation II 55
4.5 Market Share 56
4.6 Five Forces Analysis 57
4.7 Market Forecasts 64
CHAPTER 5 MACROECONOMIC INDICATORS 65
CHAPTER 6 APPENDIX 67
6.1 Data Research Methodology 67


LIST OF TABLES
Table 1: Netherlands Biotechnology Market Value: $ million, 2004-2008 12
Table 2: Netherlands Biotechnology Market Segmentation I: % Share, by Value, 2008 13
Table 3: Netherlands Biotechnology Market Segmentation II: % Share, by Value, 2008 14
Table 4: Netherlands Biotechnology Market Value Forecast: $ million, 2008-2013 21
Table 5: Netherlands Generics Market Value: $ million, 2004-2008 24
Table 6: Netherlands Generics Market Segmentation I: % Share, by Value, 2008 25
Table 7: Netherlands Generics Market Segmentation II: % Share, by Value, 2008 26
Table 8: Netherlands Generics Market Value Forecast: $ million, 2008-2013 34
Table 9: Netherlands OTC Pharmaceuticals Market Value: $ million, 2004-2008 37
Table 10: Netherlands OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008 38
Table 11: Netherlands OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008 39
Table 12: Netherlands OTC Pharmaceuticals Market Share: % Share, by Value, 2008 40
Table 13: Netherlands OTC Pharmaceuticals Distribution: % Share, by Value, 2008 49
Table 14: Netherlands OTC Pharmaceuticals Market Value Forecast: $ million, 2008-2013 50
Table 15: Netherlands Pharmaceuticals Market Value: $ billion, 2005-2009 53
Table 16: Netherlands Pharmaceuticals Market Segmentation I: % Share, by Value, 2009 54
Table 17: Netherlands Pharmaceuticals Market Segmentation II: % Share, by Value, 2009 55
Table 18: Netherlands Pharmaceuticals Market Share: % Share, by Value, 2009 56
Table 19: Netherlands Pharmaceuticals Market Value Forecast: $ billion, 2009-2014 64
Table 20: Netherlands Size of Population (million) , 2005-2009 65
Table 21: Netherlands GDP (Current Prices, $ billion), 2005-2009 65
Table 22: Netherlands Inflation, 2005-2009 66
Table 23: Netherlands Exchange Rate, 2005-2009 66


LIST OF FIGURES
Figure 1: Netherlands Biotechnology Market Value: $ million, 2004-2008 12
Figure 2: Netherlands Biotechnology Market Segmentation I: % Share, by Value, 2008 13
Figure 3: Netherlands Biotechnology Market Segmentation II: % Share, by Value, 2008 14
Figure 4: Forces Driving Competition in the Biotechnology Market in the Netherlands, 2008 15
Figure 5: Drivers of Buyer Power in the Biotechnology Market in the Netherlands, 2008 16
Figure 6: Drivers of Supplier Power in the Biotechnology Market in the Netherlands, 2008 17
Figure 7: Factors Influencing the Likelihood of New Entrants in the Biotechnology Market in the Netherlands, 2008 18
Figure 8: Factors Influencing the Threat of Substitutes in the Biotechnology Market in the Netherlands, 2008 19
Figure 9: Drivers of Degree of Rivalry in the Biotechnology Market in the Netherlands, 2008 20
Figure 10: Netherlands Biotechnology Market Value Forecast: $ million, 2008-2013 21
Figure 11: Netherlands Generics Market Value: $ million, 2004-2008 24
Figure 12: Netherlands Generics Market Segmentation I: % Share, by Value, 2008 25
Figure 13: Netherlands Generics Market Segmentation II: % Share, by Value, 2008 26
Figure 14: Forces Driving Competition in the Generics Market in the Netherlands, 2008 27
Figure 15: Drivers of Buyer Power in the Generics Market in the Netherlands, 2008 29
Figure 16: Drivers of Supplier Power in the Generics Market in the Netherlands, 2008 30
Figure 17: Factors Influencing the Likelihood of New Entrants in the Generics Market in the Netherlands, 2008 31
Figure 18: Factors Influencing the Threat of Substitutes in the Generics Market in the Netherlands, 2008 32
Figure 19: Drivers of Degree of Rivalry in the Generics Market in the Netherlands, 2008 33
Figure 20: Netherlands Generics Market Value Forecast: $ million, 2008-2013 34
Figure 21: Netherlands OTC Pharmaceuticals Market Value: $ million, 2004-2008 37
Figure 22: Netherlands OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008 38
Figure 23: Netherlands OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008 39
Figure 24: Netherlands OTC Pharmaceuticals Market Share: % Share, by Value, 2008 40
Figure 25: Forces Driving Competition in the OTC Pharmaceuticals Market in the Netherlands, 2008 41
Figure 26: Drivers of Buyer Power in the OTC Pharmaceuticals Market in the Netherlands, 2008 43
Figure 27: Drivers of Supplier Power in the OTC Pharmaceuticals Market in the Netherlands, 2008 44
Figure 28: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in the Netherlands, 2008 45
Figure 29: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in the Netherlands, 2008 47
Figure 30: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in the Netherlands, 2008 48
Figure 31: Netherlands OTC Pharmaceuticals Distribution: % Share, by Value, 2008 49
Figure 32: Netherlands OTC Pharmaceuticals Market Value Forecast: $ million, 2008-2013 50
Figure 33: Netherlands Pharmaceuticals Market Value: $ billion, 2005-2009 53
Figure 34: Netherlands Pharmaceuticals Market Segmentation I: % Share, by Value, 2009 54
Figure 35: Netherlands Pharmaceuticals Market Segmentation II: % Share, by Value, 2009 55
Figure 36: Netherlands Pharmaceuticals Market Share: % Share, by Value, 2009 56
Figure 37: Forces Driving Competition in the Pharmaceuticals Market in the Netherlands, 2009 57
Figure 38: Drivers of Buyer Power in the Pharmaceuticals Market in the Netherlands, 2009 59
Figure 39: Drivers of Supplier Power in the Pharmaceuticals Market in the Netherlands, 2009 60
Figure 40: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in the Netherlands, 2009 61
Figure 41: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in the Netherlands, 2009 62
Figure 42: Drivers of Degree of Rivalry in the Pharmaceuticals Market in the Netherlands, 2009 63
Figure 43: Netherlands Pharmaceuticals Market Value Forecast: $ billion, 2009-2014 64



[Inhaltsverzeichnis ausblenden]